高力国际（Colliers）：2024年美国生命科学地产市场报告（英文版）

Long-term demand drivers for the life sciences industry are strong. Per capita expenditures on pharmaceuticals have been trending upward for decades, and dozens of countries are now spending more than 1% of GDP on these products. This is especially true in the United States, where, according to the most recent OECD data, per capita spending (excluding hospital settings) now exceeds $1,400, at more than 2% of the nation’s GDP. The industry has plenty of upside. Per the U.S. Food &